Commentary
Podcast
Although it has some daunting adverse effects, Glenn Short, PhD, said ibogaine offers unique biological and therapeutic effects.
This month, we spoke with Glenn Short, PhD, senior vice president of Early Development at atai Life Sciences, about an under-discussed psychedelic drug: ibogaine. Although it has some daunting adverse effects, Short said ibogaine offers unique biological and therapeutic effects.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa